News
etectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System
6/10/2019
GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued...
Read More
Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills
6/6/2019
Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills
Read More
etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities
6/6/2019
Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to...
Read More
etectRx’s Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study
3/4/2019
Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March...
Read More
Digital Pills May Be on the Horizon in Cancer Care
3/1/2019
CEO of etectRx, Harry Travis, spoke with Oncology Live about digital pills, like the ID-Capsule, as a possibility for improving cancer care. Read more at https://www.onclive.com/publications/Oncology-live/2019/vol-20-no-5/digital-pills-may-be-on-the-horizon-in-cancer-care?p=1
Read More
Guardian angel or watchdog? Pills of capecitabine contain sensors
2/15/2019
CEO of etectRx, Harry Travis, spoke with MDedge about the future of digital medicine and how our state-of-the-art ID-Cap system can impact the medical industry. Read more...
Read More
etectRx Officially Moves into the University of Florida’s Innovation Hub
2/26/2018
We are proud to announce that etectRx has officially moved into the UF Innovation Hub’s ultra-modern facilities, providing our team the additional lab and office...
Read More
UF’s Newly Expanded Innovation Hub Welcomes etectRx
9/18/2017
etectRx™ is committed to advancing digital health through extensive research and innovation. When considering a location for the new office, it was crucial that the facility not...
Read More
etectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System
9/7/2017
GAINESVILLE, Fla. (Sept. 7, 2017) – etectRx™, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has...
Read More
NW Arkansas Technology Summit to feature presentation from Harry Travis
8/30/2017
The theme of the 2017 Northwest Arkansas Technology Summit is Connected Devices, Connected World, which translates into the work that etectRx™ is championing in the medication...
Read More
Harry Travis, CEO of etectRx, to appear on panel at NASP Annual Meeting & Expo
8/30/2017
The National Association of Specialty Pharmacy (NASP) is hosting its fifth annual meeting in Washington, DC, September 18-20, 2o17. etectRx™ is proud that Harry Travis will...
Read More
Smart Capsules are a Promising Tool to Improve Medication Adherence in Clinical Trials
6/1/2017
Smart Capsules are a Promising Tool to Improve Medication Adherence i/n Clinical Trials
Read More